Stifel Nicolaus Analysts Give Medical Properties Trust (MPW) a $14.00 Price Target

Medical Properties Trust (NYSE:MPW) has been given a $14.00 target price by equities researchers at Stifel Nicolaus in a research note issued to investors on Thursday. The firm currently has a “hold” rating on the real estate investment trust’s stock. Stifel Nicolaus’ target price points to a potential downside of 8.74% from the company’s previous close.

MPW has been the topic of several other reports. Jefferies Financial Group lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating and set a $15.00 price target on the stock. in a research report on Tuesday, July 17th. JMP Securities set a $16.00 price objective on shares of Medical Properties Trust and gave the company a “buy” rating in a research note on Monday, October 1st. Finally, Zacks Investment Research downgraded shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Thursday, October 25th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. Medical Properties Trust presently has an average rating of “Hold” and an average price target of $14.28.

MPW traded down $0.16 on Thursday, hitting $15.34. 4,169,652 shares of the company were exchanged, compared to its average volume of 2,268,082. The company has a current ratio of 4.92, a quick ratio of 2.19 and a debt-to-equity ratio of 0.90. Medical Properties Trust has a fifty-two week low of $11.82 and a fifty-two week high of $15.57. The firm has a market capitalization of $5.60 billion, a P/E ratio of 10.65, a PEG ratio of 3.23 and a beta of 0.47.

Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.01. Medical Properties Trust had a net margin of 124.88% and a return on equity of 9.06%. The company had revenue of $197.00 million for the quarter, compared to analyst estimates of $192.64 million. During the same period in the prior year, the business posted $0.33 earnings per share. The firm’s revenue for the quarter was up 11.6% compared to the same quarter last year. Analysts predict that Medical Properties Trust will post 1.37 EPS for the current year.

In other news, Director Michael G. Stewart sold 12,400 shares of the firm’s stock in a transaction on Friday, October 12th. The shares were sold at an average price of $14.13, for a total value of $175,212.00. Following the transaction, the director now owns 231,039 shares of the company’s stock, valued at approximately $3,264,581.07. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP James Kevin Hanna sold 15,000 shares of the firm’s stock in a transaction on Friday, August 17th. The shares were sold at an average price of $14.84, for a total transaction of $222,600.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 165,809 shares of company stock worth $2,456,679. 0.83% of the stock is currently owned by insiders.

Hedge funds have recently modified their holdings of the company. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in shares of Medical Properties Trust in the 2nd quarter valued at $104,000. Cornerstone Wealth Management LLC acquired a new stake in Medical Properties Trust during the 2nd quarter valued at $583,000. Valeo Financial Advisors LLC acquired a new stake in Medical Properties Trust during the 2nd quarter valued at $128,000. Integrated Investment Consultants LLC acquired a new stake in Medical Properties Trust during the 2nd quarter valued at $136,000. Finally, Investors Asset Management of Georgia Inc. GA ADV acquired a new stake in Medical Properties Trust during the 2nd quarter valued at $140,000. 76.88% of the stock is currently owned by institutional investors and hedge funds.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Recommended Story: How is a Moving Average Calculated?

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply